Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

The EphA3 Antibody Enhances CD47 Antibody-Mediated Phagocytosis by Repolarizing M2-Like Tumor-Associated Macrophages in a Preclinical Model of Recurrent Head and Neck Cancer

Saved in:
Bibliographic Details
Published in:OncoTargets and Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868552794390134785
collection WordPress RSS
FRELIP Feed Integration
container_title OncoTargets and Therapy
description
discipline_display Oncology
discipline_facet Oncology
format Online Article
RSS Article
genre Journal Article
id rss_article:61296
institution FRELIP
journal_source_facet OncoTargets and Therapy
last_indexed 2026-06-20T21:26:42.861Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle The EphA3 Antibody Enhances CD47 Antibody-Mediated Phagocytosis by Repolarizing M2-Like Tumor-Associated Macrophages in a Preclinical Model of Recurrent Head and Neck Cancer
Oncology
General
Oncology
sub_discipline_display General
sub_discipline_facet General
subject_display Oncology
General
Oncology
subject_facet Oncology
General
Oncology
title The EphA3 Antibody Enhances CD47 Antibody-Mediated Phagocytosis by Repolarizing M2-Like Tumor-Associated Macrophages in a Preclinical Model of Recurrent Head and Neck Cancer
title_alt El anticuerpo EphA3 mejora la fagocitosis mediada por anticuerpos CD47 al repolarizar macrófagos asociados a tumores tipo M2 en un modelo preclínico de cáncer de cabeza y cuello recurrente
L'anticorps anti-EphA3 améliore la phagocytose médiée par l'anticorps anti-CD47 en repolarisant les macrophages associés aux tumeurs de type M2 dans un modèle préclinique de cancer récurrent de la tête et du cou
O anticorpo EphA3 aumenta a fagocitose mediada por anticorpo CD47 ao repolarizar macrófagos associados a tumor tipo M2 em um modelo pré-clínico de câncer de cabeça e pescoço recorrente
title_auth The EphA3 Antibody Enhances CD47 Antibody-Mediated Phagocytosis by Repolarizing M2-Like Tumor-Associated Macrophages in a Preclinical Model of Recurrent Head and Neck Cancer
title_es_txt El anticuerpo EphA3 mejora la fagocitosis mediada por anticuerpos CD47 al repolarizar macrófagos asociados a tumores tipo M2 en un modelo preclínico de cáncer de cabeza y cuello recurrente
title_fr_txt L'anticorps anti-EphA3 améliore la phagocytose médiée par l'anticorps anti-CD47 en repolarisant les macrophages associés aux tumeurs de type M2 dans un modèle préclinique de cancer récurrent de la tête et du cou
title_full The EphA3 Antibody Enhances CD47 Antibody-Mediated Phagocytosis by Repolarizing M2-Like Tumor-Associated Macrophages in a Preclinical Model of Recurrent Head and Neck Cancer
title_fullStr The EphA3 Antibody Enhances CD47 Antibody-Mediated Phagocytosis by Repolarizing M2-Like Tumor-Associated Macrophages in a Preclinical Model of Recurrent Head and Neck Cancer
title_full_unstemmed The EphA3 Antibody Enhances CD47 Antibody-Mediated Phagocytosis by Repolarizing M2-Like Tumor-Associated Macrophages in a Preclinical Model of Recurrent Head and Neck Cancer
title_pt_txt O anticorpo EphA3 aumenta a fagocitose mediada por anticorpo CD47 ao repolarizar macrófagos associados a tumor tipo M2 em um modelo pré-clínico de câncer de cabeça e pescoço recorrente
title_short The EphA3 Antibody Enhances CD47 Antibody-Mediated Phagocytosis by Repolarizing M2-Like Tumor-Associated Macrophages in a Preclinical Model of Recurrent Head and Neck Cancer
title_sort the epha3 antibody enhances cd47 antibody-mediated phagocytosis by repolarizing m2-like tumor-associated macrophages in a preclinical model of recurrent head and neck cancer
topic Oncology
General
Oncology
url https://www.dovepress.com/the-epha3-antibody-enhances-cd47-antibody-mediated-phagocytosis-by-rep-peer-reviewed-fulltext-article-OTT